Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
PRESS RELEASES
Citius Holds Webinar Series On Conducting Mino-Lok Phase 3 Trial During COVID-19
By PR Newswire
Dec 15, 2020 9:40 AM EST
PRESS RELEASES
Citius Pharmaceuticals Receives FDA Response And Guidance To Pre-IND Consultation Submission For Mino-Wrap
By PR Newswire
Dec 9, 2020 9:40 AM EST
PRESS RELEASES
Citius Pharmaceuticals Subsidiary NoveCite Announces Data From A Study Of Induced Mesenchymal Stem Cell ("i-MSC") Therapy In An In Vivo Model Of Acute Respiratory Distress Syndrome ("ARDS")
By PR Newswire
Dec 8, 2020 9:15 AM EST
PRESS RELEASES
Citius Pharmaceuticals To Present Corporate Update At Benzinga Global Small Cap Conference On December 8
By PR Newswire
Dec 3, 2020 3:30 PM EST
PRESS RELEASES
Citius Announces Results Of Study That Mino-Lok Eradicates S. Aureus Biofilm More Effectively And Expeditiously Than Components
By PR Newswire
Nov 30, 2020 9:15 AM EST
PRESS RELEASES
Citius Pharmaceuticals To Present At Virtual Fall Investor Summit
By PR Newswire
Nov 10, 2020 9:30 AM EST
PRESS RELEASES
Citius Pharmaceuticals To Present At H.C. Wainwright 6th Annual Israel Conference
By PR Newswire
Nov 9, 2020 9:30 AM EST
PRESS RELEASES
Citius Pharmaceuticals Issues October 2020 Letter To Shareholders
By PR Newswire
Oct 27, 2020 9:00 AM EDT
PRESS RELEASES
Novellus Therapeutics Exclusively Licenses Induced Mesenchymal Stem Cells (iMSCs) To NoveCite For COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) And Other Acute Respiratory Conditions
By PR Newswire
Oct 13, 2020 7:30 AM EDT
PRESS RELEASES
Citius's Mino-Lok Trial Sites Resupplied With Registration Batch Product
By PR Newswire
Sep 30, 2020 9:45 AM EDT
PRESS RELEASES
Citius Pharmaceuticals Reports Positive Results From Recent Data Monitoring Committee Meeting For Mino-Lok Phase 3 Trial
By PR Newswire
Sep 29, 2020 10:17 AM EDT
PRESS RELEASES
Citius Pharmaceuticals Achieves Chemical Manufacturing And Control Milestones For Mino-LokĀ®
By PR Newswire
Sep 22, 2020 8:15 AM EDT
PRESS RELEASES
Citius Files Addendum To Mino-Lok Phase 3 Trial Record Keeping Protocol To Advance Trials With COVID-19 Compliance
By PR Newswire
Sep 15, 2020 10:17 AM EDT
PRESS RELEASES
Citius Pharmaceuticals To Present At H.C. Wainwright Virtual 22nd Annual Global Investment Conference
By PR Newswire
Sep 8, 2020 10:00 AM EDT
PRESS RELEASES
Citius Pharmaceuticals To Present At The LD 500 Virtual Conference
By PR Newswire
Aug 27, 2020 9:00 AM EDT
PRESS RELEASES
Citius Pharmaceuticals Announces Improved Design And Expansion Of Intellectual Property For Mino-Wrap
By PR Newswire
Aug 26, 2020 10:00 AM EDT
PRESS RELEASES
Citius Pharmaceuticals To Present At The MoneyShow Las Vegas Virtual Expo
By PR Newswire
Aug 13, 2020 9:45 AM EDT
PRESS RELEASES
Citius Pharmaceuticals Announces Closing Of $9.6 Million Bought Deal Offering And Full Exercise Of Underwriter's Option To Purchase Additional Shares
By PR Newswire
Aug 10, 2020 3:18 PM EDT
PRESS RELEASES
Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering To $8.4 Million
By PR Newswire
Aug 5, 2020 9:00 PM EDT
PRESS RELEASES
Citius Pharmaceuticals Announces $6.0 Million Bought Deal Offering
By PR Newswire
Aug 5, 2020 5:32 PM EDT
PRESS RELEASES
Citius Submits Mino-Wrap Briefing Package To FDA For Pre-IND Consult
By PR Newswire
Aug 4, 2020 8:17 AM EDT
PRESS RELEASES
Citius Pharmaceuticals Forms Scientific Advisory Board For The Planned Development Of Its Proprietary Treatment For Acute Respiratory Disease Associated With COVID-19
By PR Newswire
Jul 22, 2020 10:30 AM EDT
PRESS RELEASES
Citius Pharmaceuticals To Present At The MoneyShow Accredited Investor Virtual Event
By PR Newswire
Jul 20, 2020 2:00 PM EDT
PRESS RELEASES
Citius Pharmaceuticals Brings On Myron S. Czuczman, M.D. As Chief Medical Officer (CMO) And Executive Vice President
By PR Newswire
Jul 14, 2020 8:47 AM EDT